rovatirelin
Small moleculeexperimental
Clinical trial activity
9 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
9
Phase 3
6
Phase 4
0
Earliest trial started Mar 16, 2009 (NCT00863538)
Timeline
Indications
Mechanism of action
Thyrotropin-releasing hormone receptor agonist
- Thyrotropin-releasing hormone receptorSupplementation
TRHR supplementation
Chemistry & pharmacology
Loading structure…
SMILES
C[C@@H]1OC(=O)N[C@@H]1C(=O)N[C@@H](Cc1cscn1)C(=O)N1CCC[C@H]1C- Mol. weight
- 366.44 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297622 ↗
Also known as
- kps-0373
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07040137 | Phase 3 | Jul 31, 2025 | Kissei Pharmaceuticals |
| NCT02889302 | Phase 3 | Aug 31, 2016 | Kissei Pharmaceuticals |
| NCT01970111 | Phase 3 | Oct 22, 2013 | Kissei Pharmaceuticals |
| NCT01970098 | Phase 3 | Oct 22, 2013 | Kissei Pharmaceuticals |
| NCT01970124 | Phase 3 | Oct 22, 2013 | Kissei Pharmaceuticals |
| NCT01970137 | Phase 3 | Oct 22, 2013 | Kissei Pharmaceuticals |
| NCT01384435 | Phase 2 | Jun 23, 2011 | Kissei Pharmaceuticals |
| NCT01004016 | Phase 2 | Oct 27, 2009 | Kissei Pharmaceuticals |
| NCT00863538 | Phase 2 | Mar 16, 2009 | Kissei Pharmaceuticals |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kissei Pharmaceuticals | For profit | 9 | 9 | 2 | 2009 |
1 organizations
Page 1 / 1